Related Experiment Video
Updated: Mar 14, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Erectile dysfunction in young men with type 1 diabetes.
M I Maiorino1, G Bellastella1, E Della Volpe1
1Endocrinology and Metabolic Diseases Unit, Department of Medical, Surgical, Neurological, Metabolic Sciences and Aging, Second University of Naples, Naples, Italy.
Erectile dysfunction (ED) is more common in young men with type 1 diabetes than in healthy individuals. Depression is linked to ED in this population, regardless of insulin treatment method.
Area of Science:
- Endocrinology
- Urology
- Psychiatry
Background:
- Erectile dysfunction (ED) is a frequent complication of diabetes mellitus.
- Prevalence and factors associated with ED in type 1 diabetes, particularly in young adults, are not well-established.
- Understanding ED in type 1 diabetes is crucial for improving patient quality of life.
Purpose of the Study:
- To determine the prevalence of ED in young men (18-35 years) with type 1 diabetes.
- To compare ED rates between different intensive insulin regimens: multiple daily injections (MDI) and continuous subcutaneous insulin infusion (CSII).
- To identify correlates of ED in this population, including psychological factors.
Main Methods:
- A cross-sectional study involving 151 men with type 1 diabetes and 60 healthy controls.
- Participants completed the International Index of Erectile Function (IIEF-5) and questionnaires on quality of life, physical activity, and depressive symptoms.
- Diabetic participants were stratified based on insulin delivery method (MDI or CSII).
Main Results:
- The prevalence of ED was significantly higher in men with type 1 diabetes (37%) compared to controls (6%).
- ED prevalence was similar between MDI (36%) and CSII (39%) treatment groups.
- Diabetic men with ED exhibited lower weight, BMI, fasting glucose, insulin dose, HDL-C, and higher depression scores (SRDS).
- Self-Rating Depression Score (SRDS) was the only independent predictor of ED in the overall diabetic cohort.
Conclusions:
- Young men with type 1 diabetes have a substantially higher prevalence of ED compared to their healthy peers.
- Insulin treatment modality (MDI vs. CSII) did not significantly impact ED prevalence.
- Depression is a significant correlate of ED in young men with type 1 diabetes, highlighting the need for integrated care.
Related Concept Videos
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

